Centessa Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CNTA and buy or sell other stocks, ETFs, and their options commission-free!About CNTA
Centessa Pharmaceuticals Plc operates as clinical-stage pharmaceutical company, which engages in the discovery, development, and delivery of medicines that are transformational for patients. It is primarily focused on developing orexin receptor agonists for neurological and neurodegenerative disorders, including programs targeting narcolepsy, idiopathic hypersomnia, and other neuropsychiatric conditions, as well as its early-stage LockBody immuno-oncology platform.
CEOMario Alberto Accardi, PhD
CEOMario Alberto Accardi, PhD
Employees118
Employees118
HeadquartersAltrincham, Cheshire
HeadquartersAltrincham, Cheshire
Founded2013
Founded2013
Employees118
Employees118
CNTA Key Statistics
Market cap6.27B
Market cap6.27B
Price-Earnings ratio-22.82
Price-Earnings ratio-22.82
Dividend yield—
Dividend yield—
Average volume3.05M
Average volume3.05M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$40.56
52 Week high$40.56
52 Week low$12.76
52 Week low$12.76
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.